Rapid tumor regression from PD-1 inhibition after anti-CD19 chimeric antigen receptor T-cell therapy in refractory diffuse large B-cell lymphoma

Detalles Bibliográficos
Autores principales: Hill, Brian T., Roberts, Zachary J., Xue, Allen, Rossi, John M., Smith, Mitchell R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2019
Materias:
Correspondence
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7269903/
https://www.ncbi.nlm.nih.gov/pubmed/31471571
http://dx.doi.org/10.1038/s41409-019-0657-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7269903/
https://www.ncbi.nlm.nih.gov/pubmed/31471571
http://dx.doi.org/10.1038/s41409-019-0657-3

Ejemplares similares